US-based DuPont has announced an agreement to sell its Aramids business, which includes the globally renowned Kevlar and Nomex brands, to Arclin, a portfolio company of TJC, in a transaction valued at $1.8 billion. The deal, subject to regulatory approval, is expected to close in the first quarter of 2026.
Under the terms, DuPont will receive $1.2 billion in cash, a $300 million note receivable, and retain a 17.5% equity stake in the future Arclin entity, currently valued at $325 million. DuPont CEO Lori Koch said the divestiture aligns with the company’s strategy of portfolio optimization, allowing it to focus on higher-margin, growth-oriented segments while maximizing shareholder value through significant cash inflow and continued participation in Arclin’s growth.
For Arclin, the acquisition marks a major expansion in scale and global reach. CEO Bradley Bolduc emphasized that adding Kevlar and Nomex will transform Arclin’s portfolio, enhancing its ability to deliver innovative, safety-focused products such as Arclin Firepoint. He described the acquisition as a “unique opportunity” to expand market leadership and growth potential.
The Aramids unit, with about 1,900 employees and five manufacturing sites, generated $1.3 billion in net sales in 2024. Kevlar and Nomex are widely used in high-performance, safety-critical applications across industries, from protective gear to aerospace and automotive. The divestiture will not affect DuPont’s planned spin-off of its electronics business, Qnity, scheduled for November 1, 2025.
Advisors on the transaction include Centerview Partners and Goldman Sachs for DuPont, with Skadden, Arps, Slate, Meagher & Flom LLP as legal counsel. Piper Sandler & Company advised TJC/Arclin, with Kirkland & Ellis LLP providing legal support. At $1.8 billion, the deal underscores the growing importance of high-performance materials while reshaping DuPont’s strategic focus.
